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Abstract
Cardiac tumors can be primary or metastatic, the latter being more frequent and usually 
of pulmonary or hematologic origin. These patients’ clinical signs are non-specific and 
the electrocardiogram (ECG) can assume many patterns, among which, ST-segment 
elevation. Nevertheless, associated occlusion of the coronary arteries is rare in these 
situations.
We present a 79-year-old woman with a history of pulmonary neoplasia who was admitted 
to the emergency department due to prolonged atypical chest pain, cough and worsening 
dyspnea in the previous 3 days. The ECG revealed an ST-segment elevation in the lateral 
leads, despite normal blood work, with only residually elevated troponin I. Due to the 
disparity between the patient’s symptoms and the ECG findings, a decision was made not 
to proceed to primary angioplasty, but to further investigate with echocardiography, which 
revealed a mass localized in the anterolateral and inferolateral left ventricle walls, confirmed 
by computed tomography. The patient was admitted in the medical ward for symptomatic 
management. Her clinical condition gradually deteriorated due to the disease’s natural 
evolution and she died two weeks later.
This case highlights the importance to keep in mind differential diagnoses to acute coronary 
syndromes, when a ST-segment elevation is encountered on a ECG.
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The electrocardiogram (ECG) is one of the most frequently 
used diagnostic exams in the medical daily basis. Despite be-
ing broadly available for more than a century, its composition 
remains unchanged, as does its place as a first line diagnostic 
exam in the approach of many cardiac diseases, being irreplace-
able in the evaluation of thoracic pain syndromes. However, 
like in every diagnostic exam, the clinical context must never 
be dismissed, as many situations other than acute myocardi-
al infarction (normal variant, pericarditis, hyperkalemia, and 
pulmonary embolism) may cause ST-segment elevation [1, 2]. 
This clinical interpretation, being decisive for the immediate 
treatment of the ST-segment elevation myocardial infarction 
(STEMI), becomes of paramount importance in hospitals 
without conditions for primary angioplasty. Even though it’s a 
rare presentation, tumoral myocardial invasion may be respon-
sible for many ECG abnormalities including bradycardia, atrial 
fibrillation, atrial or ventricular extrasystoles or even ST-seg-
ment elevations, the latter mimicking a STEMI [3, 4].
CASE REPORT
A 79-year-old, caucasian woman, partially dependent on her 
activities of daily life due to physical deterioration, but with 
preserved cognition, presented to the emergency depart-
ment. She complained of 3-day worsening dyspnea, nonpro-
ductive cough and right sided thoracic pain radiating to the 
right shoulder. The pain had an intensity of 3 in 10, had no 
aggravating or improving factors and was described as a per-
sistent pressure on the right side of the chest that had had few 
or none free from any pain moments during this period.
She had a history of arterial hypertension and stage IIIB un-
differentiated big cell lung cancer (diagnosed 8 years before), 
under palliative care as the patient had refused chemothera-
py. She was medicated with Paracetamol/Codeine 500 + 30 
mg, Furosemide 40 mg, Ramipril 2.5 mg and Bromazepam 
1.5 mg. On admission, she was alert and fully oriented, her 
blood pressure was 111/84 mmHg, pulse 155 beats per min-
ute, temperature 36.7ºC, oxygen saturation 94% without sup-
plementary oxygen, and with a respiratory rate of 23 breaths 
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per minute. There were bilateral basal crackles on the lungs, 
and the heart sounds were normal. The arterial blood gas re-
vealed a respiratory alkalosis (pH 7.53, pCO2 29, pO2 64, 
HCO3- 24.2, SatO2 94%) and the ECG a sinus tachycardia 
with a 2.5 mm ST-segment elevation on leads DI, DII, aVL 
and V5-V6, without Q waves, and reciprocal ST-segment de-
pression on leads DIII, aVR and V1-V3 (Fig 1).
Considering the relative discordance between patient’s symp-
toms and the ECG findings, on top of the patient’s general condi-
tion, a decision was made not to proceed to primary angioplasty, 
but to gather further information. Transthoracic echocardio-
gram showed a mass with a maximal thickness of 21 mm, local-
ized in the antero-lateral and infero-lateral walls (Figs 2 and 3), 
rendering them akinetic, without other segmental contractility 
abnormalities, but already originating moderately depressed left 
ventricular function. Blood analysis identified a normocytic nor-
mochromic anemia, leukocytosis with neutrophilia, increased 
C reactive protein, hyponatremia, and increased D-dimers and 
troponin I (Table 1). A computed tomography (CT) scan (re-
quested to exclude pulmonary thromboembolism) confirmed 
the presence of a pericardial mass involving the left ventricle (Fig 
4), and showed signs of pulmonary distal pulmonary embolism 
as well as a bilateral pleural effusion, multiple atelectasis and nod-
ular lesions suggesting neoplastic dissemination and destruction 
of the costal arches.
Figure 1: Presentation Eletrocardiogram Showing ST-segment Ele-
vation in the Lateral Leads, without Clear Q waves, and Reciprocal 
ST-segment Depression in the Antero-septal Leads.
Figure 2: Echocardiographic Parasternal Short Axis View at the 
Left Ventricle Mid Level, with Wall Thickness Measured on AHA 
Segments from Antero-septal (1) to Infero-septal (6). Despite low 
image quality, it is visible assimetrical hypertrophy in the lateral (3) 
and posterior (4) walls. Mild pericardial effusion (12 mm).
Figure 3: Echocardiogram in the Parasternal Long Axis View. Con-
firmation of significative hypertrophy of the posterior wall, reaching 
21 mm (2).
Figure 4: Thoracic Computed Tomographic Scan, requested on 
the diagnosis doubt of concomitant pulmonary thromboembolism, 
showing a pericardial mass envolving the left ventricle, along with 
billateral pleural effusion.
During a 24-hour period of vigilance in the emergency de-
partment no increase in troponin I was documented. After-
wards, the patient was admitted to a medical ward for symp-
tomatic control, with the diagnosis of left ventricle invasion 
by lung carcinoma, pulmonary embolism, upper respiratory 
tract infection and a probable syndrome of inappropriate 
secretion of antidiuretic hormone. The pain was controlled 
with intravenous morphine, the infection treated with Amox-
icillin/Clavulanic acid, the heart rate controlled with Carve-
dilol 12.5 mg every 12 hours and hipocoagulation pursued 
with enoxaparin. The ECG pattern remained unchanged for 
the duration of the admission. Despite all measures, the pa-
tient’s clinical condition progressively deteriorated, and she 
died 2 weeks after admission.
DISCUSSION
Seventy-five percent of primary cardiac tumors are benign, 
mixoma being the most frequent [5]. Malignant tumors are 
majorly secondary, originating in the lung, breast and he-
matological system, being their composite about 20 times 
more frequent that primary Malignant cardiac tumors [6, 7]. 
Pulmonary mesothelioma and melanoma have a particular
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Table 1: Resumed Blood Work
Blood Work Result Reference Values
Hemoglobin g/dL 10.6 12.0 - 16.0
Leucocytes (mm3) 26.1 4.0 - 11.0
Neutrophils (mm3) 23.0 1.8 - 8.0
Sodium (mmol/L) 128 136 - 145
D-dimers (ng/mL) 1600 < 230
Troponin I (ng/mL) 0.254 < 0.012
Myoglobin (ng/mL) 67.4 < 140
B Natriuretic Peptide (ng/mL) 1425 < 100
Creatinine Kinase (U/L) 21 29 - 168
C Reactive protein (mg/L) 117 < 5.0
tendency for cardiac invasion [8]. The pericardium is the 
most frequently involved site of invasion, being the myocar-
dium and endocardium progressively rare [8].This involve-
ment, by metastatic cancer, can occur through lymphatic, he-
matologic or direct invasion and is indicative of a poor short 
term prognosis [6].
Patients’ clinical presentation is normally with indolent dys-
pnea, cough and thoracic pain resembling stable angina, and 
about 50% of patients will have the diagnosis of malignancy 
only when the cardiac symptoms ensue [4]. The ECG may 
show bradycardia, atrial fibrillation, T wave inversion, bun-
dle branch block or low voltage, among others. However, the 
most characteristic pattern in cardiac metastatic cancer is a 
persistent ST-segment elevation without Q waves [2, 4, 9]. 
Different pathophysiologic explanations have been proposed 
for the ECG changes, like inflammatory response, ionic trans-
fer of potassium from necrotic tissue to the adjacent myocar-
dium or muscle fibers overstretching. However no consensus 
has been reached [4]. Occlusion of a coronary artery is very 
rare though, and has no role in the repolarization changes [3]. 
In our case, the patient had already a known neoplasia and a 
non-acute thoracic pain with associated dyspnea. Her ECG 
was compatible with the classic pattern associated with car-
diac tumor invasion and, as expected, remained immutable 
throughout the hospitalization. Despite the exact mechanism 
responsible for the ECG changes being unclear, those chang-
es seem to be dependent upon the tumor’s location. Suga T 
et al. reported that in cases of posterolateral, anterolateral or 
apical/anterolateral invasion, the ST-segment elevation is 
present in the lateral and precordial leads, respectively [4]. In 
his report only one patient had diffuse pericardial metastases 
affecting all cardiac chambers, having symptoms of constric-
tive pericarditis and diffuse precordial ST-segment elevation. 
Our patient’s ECG shown ST-segment elevation in DI, DII, 
aVL and V5-V6, congruent to the location of the tumor inva-
sion and in concordance with usual findings [4].
The echocardiogram and the CT were the chosen methods 
to determine the tumor’s location and delineate its margins. 
Echocardiogram’s noninvasiveness and availability make it 
an excellent first line exam to characterize the tumor’s mor-
phology and cardiac functional compromise [10]. The CT 
and magnetic resonance have further therapeutic implica-
tions, as they stage the neoplasia [10]. The reported mor-
tality of this situation is high, at a reported 50% short-term 
mortality (2 to 3 months) [4]. Other reviews did not report 
outcomes. 
Despite being rare, secondary cardiac tumor involvement 
produces characteristic ECG changes. When confronted 
with ST-segment elevation, a clinic must confirm the pres-
ence of an acute coronary syndrome, without automatically 
dismiss other differential diagnosis. In cancer patients with 
this ECG pattern and atypical thoracic pain, cardiac metas-
tization should be considered among the diagnostic possi-
bilities, considering the immediate therapeutic implications.
ACKNOWLEDGEMENTS
We would like to thank Prof. Luís Martins for kindly share 
the case with us.
FUNDING
Authors declared there is no funding or support.
REFERENCES
1. Hanna EB, Glancy DL. ST-segment elevation: Differential diagno-
sis, caveats. Cleve Clin J Med. 2015;82(6):373-84. DOI: 10.3949/
ccjm.82a.14026 PMID: 26086496
2. Wang K, Asinger RW, Marriott HJ. ST-segment elevation in con-
ditions other than acute myocardial infarction. N Engl J Med. 
2003;349(22):2128-35. DOI: 10.1056/NEJMra022580 PMID: 
14645641
3. Cheon DY, Park KH, Hong SE, Lee SH, Jang SH, Park WJ. Metastatic 
cardiac tumor manifested by persistent ST-segment elevation with 
coexisting reciprocal changes on electrocardiography. Int Heart J. 
2014;55(5):466-8. PMID: 25088581
4. Suga T, Akuzawa N, Hatori T, Imai K, Kitahara Y, Kurabayashi M. 
ST segment elevation in secondary cardiac cancer: a case report and 
review of the literature. Int J Clin Exp Med. 2015;8(5):7719-27. 
PMID: 26221322
5. Reynen K. Cardiac myxomas. N Engl J Med. 1995;333(24):1610-7. 
DOI: 10.1056/NEJM199512143332407 PMID: 7477198
6. Goldberg AD, Blankstein R, Padera RF. Tumors metastatic to the 
heart. Circulation. 2013;128(16):1790-4. DOI: 10.1161/CIRCU-
LATIONAHA.112.000790 PMID: 24126323
7. Reynen K, Kockeritz U, Strasser RH. Metastases to the heart. Ann 
Oncol. 2004;15(3):375-81. PMID: 14998838
8. Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastases. 
J Clin Pathol. 2007;60(1):27-34. DOI: 10.1136/jcp.2005.035105 
PMID: 17098886
9. Hartman RB, Clark PI, Schulman P. Pronounced and prolonged ST 
segment elevation: a pathognomonic sign of tumor invasion of the 
heart. Arch Intern Med. 1982;142(10):1917-9. PMID: 7125773
10. Buckley O, Madan R, Kwong R, Rybicki FJ, Hunsaker A. Cardi-
ac masses, part 1: imaging strategies and technical considerations. 
AJR Am J Roentgenol. 2011;197(5):W837-41. DOI: 10.2214/
AJR.10.7260 PMID: 22021530
